Search Results - O’shea, Frankie

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Outcome in Poor Grade Subarachnoid Hemorrhage Patients Treated with Acute Endovascular Coiling of Aneurysms and Aggressive Intensive Care

    Outcome in Poor Grade Subarachnoid Hemorrhage Patients Treated with Acute Endovascular Coiling of Aneurysms and Aggressive Intensive Care by Taylor, Christopher J., Robertson, Fergus, Brealey, David, O’shea, Frankie, Stephen, Tina, Brew, Stefan, Grieve, Joan P., Smith, Martin, Appleby, Ian

    Published in Neurocritical care
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Symptom‐based staging for logopenic variant primary progressive aphasia

    Symptom‐based staging for logopenic variant primary progressive aphasia by Hardy, Chris J. D., Taylor‐Rubin, Cathleen, Taylor, Beatrice, Harding, Emma, Gonzalez, Aida Suarez, Jiang, Jessica, Thompson, Laura, Kingma, Rachel, Chokesuwattanaskul, Anthipa, Walker, Ffion, Barker, Suzie, Brotherhood, Emilie, Waddington, Claire, Wood, Olivia, Zimmermann, Nikki, Kupeli, Nuriye, Yong, Keir X. X., Camic, Paul M., Stott, Joshua, Marshall, Charles R., Oxtoby, Neil P., Rohrer, Jonathan D., O'Shea, Frankie, Volkmer, Anna, Crutch, Sebastian J., Warren, Jason D.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Gendered Communication and Career Outcomes: A Construct Validation and Prediction of Hierarchical Advancement and Non-Hierarchical Rewards

    Gendered Communication and Career Outcomes: A Construct Validation and Prediction of Hierarchical Advancement and Non-Hierarchical Rewards by Weinberg, Frankie J., Treviño, Len J., Cleveland, A. O’Shea

    Published in Communication research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

    A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib by O'Shea, John, Cremona, Mattia, Morgan, Clare, Milewska, Malgorzata, Holmes, Frankie, Espina, Virginia, Liotta, Lance, O'Shaughnessy, Joyce, Toomey, Sinead, Madden, Stephen F, Carr, Aoife, Elster, Naomi, Hennessy, Bryan T, Eustace, Alex J

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions

    The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions by Abbs, Brandon, Achalia, Rashmin M, Adelufosi, Adegoke O, Aktener, Ahmet Yiğit, Beveridge, Natalie J, Bhakta, Savita G, Blackman, Rachael K, Bora, Emre, Byun, M.S, Cabanis, Maurice, Carrion, Ricardo, Castellani, Christina A, Chow, Tze Jen, Dmitrzak-Weglarz, M, Gayer-Anderson, Charlotte, Gomes, Felipe V, Haut, Kristen, Hori, Hiroaki, Kantrowitz, Joshua T, Kishimoto, Taishiro, Lee, Frankie H.F, Lin, Ashleigh, Palaniyappan, Lena, Quan, Meina, Rubio, Maria D, de Azúa, Sonia Ruiz, Sahoo, Saddichha, Strauss, Gregory P, Szczepankiewicz, Aleksandra, Thompson, Andrew D, Trotta, Antonella, Tully, Laura M, Uchida, Hiroyuki, Velthorst, Eva, Young, Jared W, O'Shea, Anne, DeLisi, Lynn E

    Published in Schizophrenia research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: